Sema3A Inhibits Osteolytic Bone Metastasis of Non-small Cell Lung Cancer

CONCLUSION: This study provides a new idea for the clinical treatment of osteolytic bone metastasis in NSCLC.PMID:38629364 | DOI:10.2174/0115748928295263240402085411

Source: Recent Patents on Anti-Cancer Drug Discovery - April 17, 2024 Category: Cancer & Oncology Authors: Wei Wang Kaicheng Shen Ruyan Liu Qi Zhou Source Type: research